Author:
Candal-Pedreira Cristina,Ruano-Ravina Alberto,Calvo de Juan Virginia,Cobo Manuel,Cantero Alexandra,Rodríguez-Abreu Delvys,Estival Anna,Carcereny Enric,Hernandez Ainhoa,López Castro Rafael,Medina Andrea,García Campelo Rosario,Fernández Bruno Manuel,Barnabé Reyes,Bosch-Barrera Joaquim,Massutí Bartomeu,Dómine Manuel,Camps Carlos,Ortega Ana Laura,Provencio Mariano
Reference37 articles.
1. GLOBOCAN 2022: Estimated Cancer Incidence MaPWiIL,2022
2. Reduced lung-cancer mortality with volume CT screening in a randomized trial;de Koning;N Engl J Med,2020
3. EUnetHTA OTCA28 Authoring Team. Lung cancer screening in risk groups. Collaborative assessment. Diemen (The Netherlands): EUnetHTA; 2020. 252. Report No. OTCA28. [accessed 15 Mar 2024] Available from: https://www.eunethta.eu.
4. Addressing lung cancer screening eligibility in Spain using 2013 and 2021 US Preventive Service Task Force criteria: cross-sectional study;Candal-Pedreira;ERJ Open Res,2023
5. Minimising diagnostic delay in lung cancer;Rogers;Thorax,2019